Evidence map›Paper›PMID 34315188›Full record

ArticlePsycho-oncology2022

Cancer patient perspective in the arena of COVID-19 pandemic.

Zelmira Ballatore, Filippo Merloni, Nicoletta Ranallo, Lucia Bastianelli, Francesca Vitarelli, Luca Cantini, Giulia Ricci, Benedetta Ferretti, Paolo Alessandroni, Michela Del Prete and 8 more

Abstract read
In one paragraph

Article in Psycho-oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. The evolution of patient-reported safety concerns during the COVID-19 pandemic within a series of study questionnaires: a multi-method analysis.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2025
    Article
  4. Article
  5. Article
  6. Cancer Patients during COVID-19 Pandemic: A Mini-Review.Healthcare (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Zelmira BallatoreClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
Filippo MerloniClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
Nicoletta RanalloClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
Lucia BastianelliClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
Francesca VitarelliClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
Luca CantiniClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
Giulia RicciClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
Benedetta FerrettiU.O. Oncologia, Ospedale B. Eustachio, San Severino, Italy.
Paolo AlessandroniU.O. Oncologia, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy.
Michela Del PreteU.O. Oncologia, Ospedale A. Murri, Fermo, Italy.
Silvia ChiorriniU.O. Oncologia, Ospedale E. Profili, Fabriano, Italy.
Mobin SafiU.O. Oncologia, Ospedale C. Urbani, Jesi, Italy.
Rita FicarelliU.O. Oncologia, Presidio Ospedaliero Unico "Santa Maria della Misericordia", Urbino, Italy.
Giovanni BenedettiU.O. Oncologia, Ospedale di Civitanova Marche, Civitanova Marche, Italy.
Luca FaloppiU.O. Oncologia, Ospedale di Macerata, Macerata, Italy.
Massimo MarcelliniU.O. Oncologia, Ospedale di Senigallia, Senigallia, Italy.
Rosa StoicoClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
Rossana BerardiClinical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.

Funding

Open Access Funding provided by Universita Politecnica delle Marche within the CRUI-CARE Agreement
6 · The paper itself

Abstract

objectiveThe coronavirus disease 2019 (COVID-19) outbreak has been declared a global pandemic of unprecedented proportions. Italy is a country which has been heavily affected. Cancer patients are at a higher risk owing to their intrinsic fragility related to their underlying disease and oncologic treatment. Against this backdrop, we conducted a survey to investigate how patients perceived their condition, clinical management and availability of information during the pandemic.

methodsBetween 15 April and 1 May 2020 a survey was submitted to cancer patients at oncology departments in the Marche region. Questions regarding the perception of personal safety, continuity of cancer care, information quality and psychological distress.

resultsSeven hundred patients participated in the survey; 59% were female and 40% were aged between 46 and 65. The majority of the participants perceived compliance with appropriate safety standards by cancer care providers and 80% were reassured about their concerns during the medical interview. 40% were worried of being at a higher risk of infection and 71% felt they were at a greater risk because of chemotherapy. 55% felt that postponing cancer treatment could reduce its efficacy, however 76% declared they did not feel abandoned at the time of treatment postponement. Patients between 46 and 65 years declared a significant reduction in sleep (p < 0.01) and in concentration (p = 0.03).

conclusionsThe emergency care offered to cancer patients has been deemed satisfactory in terms of both safety standards and care management. However, the majority of participants perceived the mutual negative influence between their oncologic disease and the risk of infection highlighting the need for special measures to ensure safe continuity of care.

Indexed as

COVID-19NeoplasmsAgedFemaleHumansMedical OncologyMiddle AgedPandemicsSARS-CoV-2Surveys and Questionnairescancercancer patientscoronavirus diseaseCOVID-19distressoncologypsycho-oncology

Identifiers

PMID34315188
PMCPMC8420223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.